Skip to main content
. 2024 Oct 25;14(11):1371. doi: 10.3390/life14111371

Table 4.

Univariate and multivariate Cox proportional hazards model results for complete response.

Complete Response
Univariate Analysis Multivariate Analysis
p-Value Hazard Ratio %95 CI p-Value Hazard Ratio %95 CI
Age at Diagnosis 0.043 * 1.014 1.001–1.028 0.065 1.015 0.999–1.030
Age of Onset of Lesions (Years) 0.140 1.010 0.997–1.022 - - -
Time to Diagnosis (Months) 0.314 1.001 0.999–1.003 - - -
Gender (Male) 0.030 * 0.660 0.250–0.960 0.028 * 0.638 0.150–0.952
Patch/Patch + Plaque (Patch + Plaque) 0.056 0.696 0.480–1.009 - - -
Morphological Findings
Hyperpigmentation (Yes) 0.377 0.815 0.519–1.282 - - -
Erythema (Yes) 0.069 1.444 0.972–2.145 - - -
Pruritus (Yes) 0.369 1.191 0.813–1.743 - - -
Histopathological Findings
Classic (Yes) 0.770 1.062 0.708–1.593 - - -
Folliculotropism (Yes) 0.870 1.078 0.437–2.659 - - -
CD8 (+) (Yes) 0.360 1.254 0.772–2.037 - - -
Stage at Diagnosis
IB 0.718 0.930 0.627–1.380 0.813 1.050 0.703–1.567
IIA 0.003 * 0.402 0.192–0.737 0.863 1.194 0.159–8.960
T Stage at Diagnosis
(T2)
0.552 0.894 0.618–1.294 - - -
N Stage at Diagnosis
Nx 0.059 0.382 0.141–1.039 - - -
N1 0.680 0.809 0.296–2.214 - - -
β-2 Microglobulin (High) 0.003 * 0.535 0.110–0.812 0.012 * 0.567 0.254–0.883
LDH (High) 0.059 0.382 0.141–1.039 - - -
Eosinophilia (Yes) 0.680 0.809 0.296–2.213 - - -
Initial Treatment Type
Skin-directed 0.571 1.155 0.702–1.900 - - -
Combined 0.850 0.952 0.573–1.583 - - -
Initial Treatment
NB-UVB 0.001 * 0.538 0.250–0.785 0.769 0.922 0.536–1.587
PUVA 0.001 * 1.990 1.338–2.961 0.018 * 1.870 1.114–3.139
PUVA + IFN 0.118 5.114 0.663–39.463 - - -

* p < 0.05 significant relationship. p > 0.05 no significant relationship; CI: confidence interval; LDH: lactate dehydrogenase; NB-UVB: Narrowband Ultraviolet B; PUVA: Psoralen + Ultraviolet A; IFN: Interferon.